February 2023

3PL vendors can leverage their expertise to create flexibility and offer enhanced sourcing strategies for providers. Whether a provider is supplementing their shared inventory strategy by stockpiling key products (like PPE) or seeking to engage in a turnkey self-distribution strategy, 3PL vendors can customize solutions for providers’ unique requirements.

On Jan. 31, Humira (adalimumab) lost its exclusivity, opening the door for at least eight adalimumab biosimilars to come to market by the end of 2023 and making now a great time to discuss the differences between these biosimilar products.

Steve Kennedy, Vizient senior consulting director, pharmacy, discusses home infusion and alternate site of care and why it’s on everyone’s mind.

Growing up, Shaleta Dunn learned firsthand the hardships of health and social inequities. Now, she puts her expertise into action by working to bolster historically under resourced and disadvantaged communities.

The latest news and information from Vizient regarding Supply Chain News.